New York City based Equilibre BioPharmaceuticals is raising $6,000,002.00 in New Equity Investment.
New York, NY – According to filings with the U.S. Securities and Exchange Commission, Equilibre BioPharmaceuticals is raising $6,000,002.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, Steven Gordon played…
